{"id":"W4383695818","doi":"10.3390/ph16070985","title":"[212Pb]Pb-eSOMA-01: A Promising Radioligand for Targeted Alpha Therapy of Neuroendocrine Tumors","year":2023,"lang":"en","type":"article","venue":"Pharmaceuticals","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"TRIUMF","funders":"European Regional Development Fund","keywords":"Biodistribution; Radionuclide therapy; Radioligand; Chemistry; In vivo; Neuroendocrine tumors; Nuclear medicine; Spect imaging; Radiochemistry; Ex vivo; Receptor; In vitro; Internal medicine; Medicine; Biochemistry; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001935163,0.0005328549,0.0002859707,0.0002590377,0.0001719482,0.0003646532,0.0003675508,0.0004190978,0.0006670185],"category_scores_gemma":[0.0001020876,0.000173516,0.0001541982,0.0003019834,0.0002126691,0.000207728,0.0002476103,0.0004193216,0.0006393648],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004296733,"about_ca_system_score_gemma":0.0003586393,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001073526,"about_ca_topic_score_gemma":0.001394438,"domain_scores_codex":[0.9999169,0.00002156096,0.000003998393,0.00001928663,0.00001823643,0.00001996697],"domain_scores_gemma":[0.9999654,0.000007126212,0.000007915398,0.000002664947,0.000006298512,0.00001060076],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003700528,0.00004835873,0.000500837,0.0001507402,0.0000141089,0.0004343168,0.0000403656,0.0008234589,0.9814453,0.0007127667,0.0004798165,0.01497984],"study_design_scores_gemma":[0.00006917372,0.0007615848,0.001573527,0.00001490116,0.00003179166,0.001910486,0.00002753234,0.001665275,0.9753284,0.0001117963,0.01848713,0.000018277],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9150164,0.02789548,0.0402492,0.0008722477,0.0001234505,0.0001839289,0.0006264198,0.0005445983,0.01448836],"genre_scores_gemma":[0.9587837,0.01027164,0.01570613,0.0003150429,0.0000356262,0.0001229874,0.001134272,0.00007235497,0.01355823],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001073526,"threshold_uncertainty_score":0.003117502,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1071141108231488,"score_gpt":0.4352716562238662,"score_spread":0.3281575454007173,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}